Literature DB >> 19014884

Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.

Andrew G Cole1, Axel Metzger, Marc-Raleigh Brescia, Lan-Ying Qin, Kenneth C Appell, Christopher T Brain, Allan Hallett, Pam Ganju, Alastair A Denholm, James R Wareing, Timothy J Ritchie, Gillian M Drake, Stuart J Bevan, Aisling MacGloinn, Andrew McBryde, Viral Patel, Paul J Oakley, Ximena Nunez, Hubert Gstach, Peter Schneider, John J Baldwin, Roland E Dolle, Edward McDonald, Ian Henderson.   

Abstract

The synthesis and identification of sulfonamido-aryl ethers as potent bradykinin B1 receptor antagonists from a approximately 60,000 member encoded combinatorial library are reported. Two distinct series of compounds exhibiting different structure-activity relationships were identified in a bradykinin B1 whole-cell receptor-binding assay. Specific examples exhibit K(i) values of approximately 10nM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19014884     DOI: 10.1016/j.bmcl.2008.11.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  A p-methoxybenzyl (PMB) protection/deprotection approach toward the synthesis of 5-phenoxy-4-chloro-N-(aryl/alkyl) thiophene-2-sulfonamides.

Authors:  Alfred L Williams; Srinivasa R Dandepally; Sharadsrikar V Kotturi
Journal:  Mol Divers       Date:  2009-11-21       Impact factor: 2.943

3.  Ruthenium-catalyzed, site-selective C-H activation: access to C5-substituted azaflavanone.

Authors:  Manickam Bakthadoss; Tadiparthi Thirupathi Reddy; Duddu S Sharada
Journal:  RSC Adv       Date:  2020-08-26       Impact factor: 3.361

4.  Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis.

Authors:  Carles Galdeano; Nicolas Coquelle; Monika Cieslikiewicz-Bouet; Manuela Bartolini; Belén Pérez; M Victòria Clos; Israel Silman; Ludovic Jean; Jacques-Philippe Colletier; Pierre-Yves Renard; Diego Muñoz-Torrero
Journal:  Molecules       Date:  2018-03-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.